Introduction
As one of the most commonly diagnosed cancers, oral cancer, especially oral squamous cell carcinoma (OSCC), is a severe cancer worldwide with high rates of metastases and recurrence. Research has reported that there is a higher occurring rate of OSCC in males than in females. 1 Similar to other cancers, a series of genetic changes are the primary cause of OSCC. 2, 3 Previous studies have shown that various types of physical, chemical or biological mutagens can increase the rate of genetic changes of OSCC. 3, 4 And a lot of genes involved in occurrence and development of OSCC have been studied. [5] [6] [7] Even though great developments have been achieved in OSCC treatments, the main therapy is still surgical intervention with radiotherapy or chemotherapy, and the overall survival rate has not significantly improved. 2, 8 Therefore, it is still urgent to acquire more knowledge, especially regarding the molecular mechanisms of cell proliferation and apoptosis in OSCC, which may lead to new potential therapy.
FAM46 genes are widely expressed in animal genomes and the encoded proteins have noncanonical poly (A) polymerases activity. There are four FMA46 paralogs expressed in humans (FAM46A, FAM46B, FAM46C, and FAM46D) and among them FAM46C mutation was found in most multiple myeloma (MM) patients. [9] [10] [11] Furthermore, research has also reported that overexpression of FAM46C can suppress cell migration and invasion in hepatocellular carcinoma cells. 12 All those studies suggested that FAM46C may be one of the tumor suppressor genes.
However, whether FAM46C can also act as a tumor suppressor gene in OSCC is still unknown. To further understand the extra function of FAM46C gene in OSCC, we overexpressed or silenced FAM46C expression level in OSCC cell lines to analyze whether FAM46C gene is involved in regulating the cell growth in OSCC. Furthermore, the activity of caspase 3 and caspase 9 were detected to confirm that the enhanced cell apoptosis induced by FAM46C overexpression was achieved through caspases pathway. The expression level of p-ERK1/2 was also detected to investigate whether ERK1/2 acts as an inhibiting factor of caspases pathway in OSCC cells. In addition, upstream regulators of ERK1/2 were also detected to explain the regulating mechanism of FAM46C on ERK1/2. In summary, our findings demonstrated that in vitro FAM46C can regulate the proliferation and apoptosis of OSCC cells via a complex downstream signaling pathway.
Material and methods cell lines and transfection
HEK293T cells, human immortalized oral epithelial cell (HIOEC) line, and the adherent OSCC cell lines from human tongue tissues (HSC4, SCC25, SCC4, SCC15, and CAL27) used in the this study were purchased from JRDUN Biothech (Shanghai, China). These cells were cultured in DMEM together with 10% fetal calf serum (FCS) and 1% antibiotic (penicillin/streptomycin) at 37°C with 5% CO 2 .
HEK293T cells were co-transfected with a lentiviral plasmid (pLVX-puro) expressing FAM46C or containing a control vector with package plasmids. The viral supernatant was collected after 48 hours of transfection and added to SCC15 and CAL27 cells. SCC15 and CAL27 cells without any treatment were used as control. The expression level of FAM46C was evaluated by real time PCR and Western blot after 48 hours of transduction.
Three FAM46C shRNAs (siFAM46C-1 5′-CCAGGG ATTGCATGTCCTT-3′, siFAM46C-2 5′-GGACGAGGC AACTTTCCAA-3′, siFAM46C-3 5′-GCAACTTCA GCAACTACTA-3′) and a control shRNA (siNC) were constructed into lentivirus (pLKO.1). The constructed lentivirus and package plasmids were co-transfected into 
Protein extraction and Western blot assay
Total proteins were extracted using RIPA lysis buffer containing protease and phosphatase inhibitors (BY240825; JRDun, Shanghai, China). Cell samples were washed twice with cold PBS and then lysed in RIPA buffer, after that the samples were kept at 4°C for several minutes. The samples were centrifuged at 12,000 g for 10 minutes and then supernatant was collected. The sample proteins were quantitated by BCA Protein Assay Kit (PICPI23223; Thermo Fisher Scientific). Equal amounts of protein (approximately 25 µg) were separated by SDS-PAGE, and transferred onto a nitrocellulose (NC) membrane (HATF00010; EMD Millipore, Billerica, MA, USA). The NC membrane was blocked with 5% skim milk at room temperature for 1 hour or 4°C overnight. The membranes were incubated with primary antibodies at room temperature for 2 hours or 4°C overnight (FAM46C, Abcam, Cambridge, UK, Ab169699; p-ERK1/2, CST (Cell Signalling Technology, Danvers, MA, USA), 9101; ERK1/2, CST, 9102; caspase 9, Abcam, Ab202068; caspase 3, Abcam, Ab44976; Ras, Solarbio, Beijing, China, K006385P; MEK1/2, CST, 9122; p-MEK1/2, CST, 4376; GAPDH, CST, 5174). After washing three times with Tris buffer with 1% Tween, an appropriate secondary horseradish peroxidase-conjugated antibody (A0208; Beyotime, Shanghai, China) was added OncoTargets and Therapy 2018:11 submit your manuscript | www.dovepress.com
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The potential functions of FaM46c in Oscc to the NC membranes and incubated at 37°C for 1 hour. The signals were visualized with enhanced chemiluminescence reagents (WBKLS0100; EMD Millipore) and pictured with Tanon-5200 system (Tanon, Shanghai, China) and the bands were analyzed with ImageJ software.
cell proliferation analysis
The cell proliferation assay was performed with Cell Counting Kit-8 (CCK-8). In short, SCC15, CAL27, and HSC4 cells were seeded onto 96-well plates (3×10 3 cells/well) and incubated overnight at 37°C. Then the SCC15 and CAL27 cells were transfected with lentivirus expressing FAM46C cDNA or containing control vector. SCC15 and CAL27 cells without any treatment were used as control. The HSC4 cells were transfected with FAM46C shRNAs lentivirus or an siNC lentivirus and exposed to 50 µmol/L U0126 (S1102; Selleck Chemicals, Boston,USA). At 0, 24, 48, and 72 hours after treatment, 100 µL medium without FCS with 10% CCK-8 (CP002; SAB Signalway Antibody, Bath, UK) was added to each well and incubated at 37°C for 1 hour. The optical density at 450 nm was read by a spectrophotometer (DNM-9602; Perlong, Beijing, China).
cell apoptosis and caspase 3/9 activity assay
The cell apoptosis rate was assessed by FACS assay and activity of caspase 3 and caspase 9 was assessed by biochemical method. Amounts of 50 µg/L EGF (236-EG; R&D Systems, Inc., Minneapolis, MN, USA), 20 µM Z-DEVD-FMK (S7312; Selleck) or 50 µmol/L U0126 (S1102; Selleck) were used in this experiment.
For cell apoptosis assay, after 48 hours of transduction, 5-10×10 3 cells were collected and labeled with Annexin V-FITC (C1063; Beyotime) at 4°C for 15 minutes and then labeled with propidium iodide (C1063; Beyotime) at 4°C for another 5 minutes. Cell apoptosis rate was analyzed by a flow cytometer (Accuri C6; BD Biosciences, San Jose, CA, USA).
The activity of caspase 3 and caspase 9 were measured by caspase 3/caspase 9 Colorimetric Assay Kit (KeyGEN, Nanjing, China) according to the manufacturer's instructions.
statistical analysis
GraphPad Prism software Version 7.0 (GraphPad Software, Inc., La Jolla, CA, USA) was used to analyze data. Data from three independent experiments were presented as mean ± SD. Results were performed by one-way or two-way ANOVA to determine the statistical significance among different groups. P,0.05 was defined as significant.
Results
The expression level of FaM46c in 5 Oscc cell lines
To study the biological functions of FAM46C in OSCC in vitro, we chose HIOEC cells and five different OSCC cell lines HSC4, SCC4, SCC25, SCC15, and CAL27 to detect the expression level of FAM46C. FAM46C mRNA expression level and protein expression level in HIOEC and OSCC cell lines were measured by real time PCR and Western blot respectively. As illustrated in Figure 1 , a different expression level of FAM46C was shown among the five OSCC cell lines in both mRNA and protein level. The expression level of FAM46C in HSC4 was higher than in HIOEC, but in SCC25, SCC15, SCC4, and CLA27 it was lower than in HIOEC and especially lower in CAL27 and SCC15.
FaM46c overexpression in Oscc cells
To test the function of FAM46C in regulating the proliferation and apoptosis of OSCC cells, we overexpressed 
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Zhuang and lu FAM46C in OSCC cells. Here, CAL27 and SCC15 OSCC cell lines were chosen to overexpress FAM46C because the expression level of FAM46C in these two cell lines was relatively lower (Figure 1) .
The CAL27 and SCC15 cells were transfected with the lentivirus expressing FAM46C or control vector and the cells without treatment served as control. As shown in Figure 2 , the FAM46C expression level was upregulated at both mRNA and protein level compared with control and vector groups in CAL27 and SCC15 cells.
FaM46c overexpression inhibits cell proliferation in Oscc cell lines
To establish whether FAM46C plays a role in regulating cell proliferation in OSCC cells, we performed CKK-8 assay with two FAM46C overexpressed OSCC cell lines (CAL27 and SCC15). The results of CCK-8 showed that, compared with control and vector groups, the cell proliferation of FAM46C overexpressed cells was significantly attenuated ( Figure 3A and B). The Western blot results ( Figure 3C and D) showed that, in FAM46C overexpressed cells, the expression levels of cleaved caspase 3 and cleaved caspase 9 were significantly higher but the expression level of p-ERK1/2 was lower compared with control and vector groups. Moreover, the expression level of Ras and p-MEK1/2, the upstream regulators of ERK, were also suppressed by FAM46C overexpression, as illustrated in Figure 3E and F. These data suggest that FAM46C can suppress the growth of OSCC cells and this pathway may be involved in the regulation of the activation of caspases and ERK1/2.
FaM46c overexpression induces the apoptosis of Oscc cells via caspase 3 and erK pathways
Our further study focused on whether the attenuated proliferation of OSCC cells with FAM46C overexpression was associated with an increase in apoptosis. We evaluated OSCC cell apoptosis by flow cytometry analysis with FAM46C overexpressed cells, together with treatment with ERK1/2 agonist (EGF) or a caspase 3 blocker (Z-DEVD-FMK) or vehicle (DMSO). The cells without any treatment served as control. As shown in Figure 4A and B, significantly increased cell apoptosis was shown in the FAM46C overexpressed group (CAL27 and SCC15) compared with vector group. The FAM46C overexpressed cells treated with EGF or Z-DEVD-FMK achieved an apparent decline in cell apoptosis compared with FAM46C overexpressed cells treated with vehicle. In addition, we evaluated the activity of caspase 3 and caspase 9, which are a kind of proapoptotic protein, by 
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The potential functions of FaM46c in Oscc biochemical method. The results (Figure 4C and D) showed that both caspase 3 and caspase 9 had higher activity in FAM46C overexpressed group compared with vector group, and both EGF and Z-DEVD-FMK could reduce the activity of caspase 3 and caspase 9. These data suggest that the cell apoptosis in FAM46C overexpressed cells was regulated via caspases and ERK pathways.
Knockdown of FaM46c inhibits cell apoptosis and induces the proliferation in Oscc cells via erK pathway
To further investigate the growth inhibition in OSCC cells, we inhibited the expression level of FAM46C in OSCC cells. As shown in Figure 1 , we chose HSC4 cells to silence FAM46C because the expression level of FAM46C in HSC4 
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Zhuang and lu was relatively higher. The constructed lentiviruses expressing FAM46C shRNAs or control shRNA (siNC) were used to infect HSC4 cells, and HSC4 cells without any treatment served as control. In Figure 5 , the results from real time PCR and Western blot showed that all three shRNAs caused a strong inhibitory effect on FAM46C at both mRNA and protein levels. siFAM46C-2 was chosen for the following experiments, because of a higher inhibitory efficiency than siFAM46C-1 and siFAM46C-3.
Next we analyzed the cell apoptosis and the proliferation in FAM46C knockdown cells (siFAM46C) and siNC. As shown in Figure 6 , a weaker apoptosis and a stronger proliferation was exhibited in FAM46C knockdown group compared with siNC group. The Western blot results showed that the protein expression levels of cleaved caspase 3 and cleaved caspase 9 were lower but p-ERK1/2 was higher in FAM46C knockdown group compared with siNC groups. Beyond that, we treated FAM46C knockdown cells and siNC cells with an ERK1/2 inhibitor (U0126). Flow cytometry assay ( Figure 6A ) and CCK-8 assay ( Figure 6B ) showed that both FAM46C knockdown and siNC groups exhibited decreased proliferation and improved apoptosis rate compared with the cells treated by vehicle (DMSO). Western blot ( Figure 6C ) also showed an associative result after being treated with U0126, the protein expression level of cleaved caspase 3 and cleaved caspase 9 was upregulated in both FAM46C knockdown cells and siNC cells, but the expression level of p-ERK1/2 was reduced. These data suggest that FAM46C can regulate the growth of OSCC cells and this may be involved in activation of caspases and ERK1/2 expression pathway.
Discussion
The tumor-inhibiting effect of FAM46C has been studied for several years, but previous research mainly focused on MM. 13, 14 Here, in this research, we found that FAM46C was also related to regulating the growth of OSCC cells 
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The potential functions of FaM46c in Oscc in vitro. First of all, we found that overexpressing FAM46C in OSCC cells could inhibit cell proliferation from CCK-8 assay. Moreover, the flow cytometry assay also showed that FAM46C induced the apoptosis of OSCC cells. Together, our findings suggest that FAM46C may inhibit the growth of OSCC cells by inducing apoptosis.
Most pathways to apoptosis involve the activation of caspases, which belong to the cysteinyl aspartate proteases group. 15 There are approximately 14 kinds of caspases. Caspase 9, a member of caspases, usually plays a role in the early stage of cell apoptosis pathway by activating caspase 3, which is usually considered as the downstream signaling molecule in cell apoptosis pathway. 16 Little is known about the pathway of FAM46C-induced apoptosis in OSCC cells. Therefore, we tested the activity of caspase 3 and caspase 9. Our results indicated that FAM46C overexpressed cell lines showed a higher activity of caspase 3 and caspase 9 and a relatively higher cell apoptosis rate compared with the vector group. Meanwhile, this activity or the higher cell apoptosis can be decreased by caspase blocker (Z-DEVD-FMK). Moreover, in FAM46C knockdown cells the protein expression level of cleaved caspase 3 and cleaved caspase 9 was downregulated compared with siNC cells. These data suggest that the pathway of FAM46C-induced apoptosis may be regulated by caspase 3/9.
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Zhuang and lu A lot of research has focused on the RAF-MEK-ERK1/2 pathway, which plays a key role in cell survival. 17 Moreover, it has been proven that RAS-ERK pathway can drive neoplasia, and abnormal RAS-ERK signaling exists in a lot of human malignancies. 18, 19 Furthermore, in this pathway, Ras acts as early signaling molecule to activate ERK1/2 and p-ERK1/2 is a final effective form which regulates cell growth. [20] [21] [22] In addition, research has shown that p-ERK1/2 inhibits the activation of caspase 9 to achieve cell proliferation. 18, 23 Our results revealed that in FAM46C overexpressed cells, the level of p-ERK1/2 was downregulated and the level of p-ERK1/2 was relatively higher in FAM46C knockdown cells. In addition, results from Western blotting showed that the expression levels of Ras and p-MEK were also significantly suppressed by FAM46C overexpression. These data suggest that FAM46C could have an inhibitory effect on the phosphorylation of ERK1/2 via Ras/MEK pathway. In addition, ERK1/2 agonist (EGF) disturbed the activity
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The potential functions of FaM46c in Oscc of caspase 3 and caspase 9 in FAM46C overexpressed cells. At the same time, the Western blot results in FAM46C knockdown cells and siNC cells showed that the treatment with ERK1/2 inhibitor (U0126) reduced the level of p-ERK1/2 and increased the expression levels of cleaved caspase 3 and cleaved caspase 9 compared with the cells exposed to vehicle. These findings clearly indicate that p-ERK1/2 can really interfere with the expression level of cleaved caspase 3 and cleaved caspase 9 which can be upregulated by FAM46C overexpression in OSCC cells.
Conclusion
In summary, our results clearly illuminate that FAM46C can reduce cell proliferation and induce cell apoptosis by activating caspase 3 and caspase 9 and at the same time inhibit the phosphorylation of ERK1/2 via Ras/MEK pathway. This is the first study describing the role of FAM46C in OSCC cells and may shed light on OSCC treatment although further experiments are needed to explore how FAM46C activates caspase 3/9 and interrupts the phosphorylation of ERK1/2.
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